The Collision Of Biologics – Emerging Competition And What To Expect
By EsqSocial Corporation 25/03/21
On 11 March 2021, GCR hosted a series of interactive webinars. Our global co-head of antitrust, Elaine Johnston, participated in the panel that looked at the development of biologics and the role that antitrust has to play in ensuring healthy price competition between biologics and biosimilars. This blog post highlights the hurdles that industry players may face as biosimilar manufacturers attempt to carve out a place for themselves in this market....
By: Allen & Overy LLP